The company has outstanding warrants to employees of Psyros Diagnostics Ltd. of 8,304,510 (corresponding to 83 045 shares) and 78,454 (corresponding to 78,454 shares) and can thus cause dilution.
Prolight Diagnostics’ share is traded on the Nordic Growth Market, NGM SME, under the name PRLD.